Klatskin-Sutker Discovery Fund
The Klatskin-Sutker Discovery Fund awards approximately $25,000 annually to one or more primary investigators in the LSI to support specific research in his or her lab. The LSI director and award committee targets the award to one or more projects that are scientifically excellent, have potential for high impact on human health, involve collaborative work across disciplines and are unlikely to be funded through traditional grants.
- Generation of a novel animal model to emulate a specific disease state
- Genetic analyses of inherited diseases
- High-throughput screening of chemical compounds for therapeutic potential against novel targets identified in cancer, neurodegenerative disease and metabolic disorders
- Evaluation of new uses for old drugs
- Structural biology studies to generate new insights into functional properties of proteins or potential drugs
- Analysis of efficacy or side effects of new medicine
Conceived of and designed by LSI’s Leadership Council, the Innovation Partnership takes on the challenge of bridging the "valley of death" for new drugs by infusing the projects of LSI scientists with funding and expertise from leaders in the top ranks of business, venture capital, and the biomedical industry. With $1.2 million raised from donors, the Innovation Partnership has funded four faculty projects, all of which have achieved critical commercialization milestones with mentorship from the ranks of the council. Fundraising continues and new faculty projects are in the pipeline.
Drug Discovery Grants
The LSI is a co-sponsor of the U-M Center for the Discovery of New Medicines, which offers seed funding of up to $50,000 toward high-throuput screening, structural biology, pharmakokentics, or medicinal chemistry work in four affilated core labs located at the LSI and College of Pharmacy.
Generous philanthopic gifts support many of our innovative, entrepreneurial projects to a point where they can receive more traditional forms of research funding. Learn more about giving to the LSI.